Home > Products > Active Pharmaceutical Ingredient (API)

Sinae Active Pharmaceutical Ingredient (API) fabrica, supplementum, Factory

Jiangsu Run'an Pharmaceutical Co, Ltd., subsidiaria omnino possessa de Jiangsu Chiatai Qingjiang Pharmaceutical Co, Ltd., modernus summus tech pharmaceuticus societas specialis in R&D, productionis et venditio fertilitatis ordinandae medicinae et varietatis APIs. Project constructionem mense Novembri 2018 incepit, LIX mu aream obtegens, cum tota obsidione 160 decies Yuan et tota area aedificium 25000 quadratum metrorum.

Praecipua activum medicamentum pharmaceuticum (API) producta: Hydrochloridem Gemcitabinum, Celecoxib, bromhexinum hydrochloridum, Iguratimod, Apremilast, Citrate Tofactinib, Crisaborole, Urapidil Hydrochloride, Sugammadex Natrium, Garlicin, Dexmedetomidine Hydrochloride, Rocuronium Bromidum, Finerenone, etc. elit mundi genus facti et productorum gignentium opificem per constantem emendationem et innovationem in technologiarum, et occasiones praeclarum negotium praebent sodalibus nostris per orbem terrarum. Munus nostrum ad praestantes operas emptores nobis permisit solidas relationes cum sociis nostris toto orbe includere.

View as  
 
(+)-N-[2-[1(S)-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4 -yl]acetamide

(+)-N-[2-[1(S)-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4 -yl]acetamide

Seres operis nomen: Aprester
Sinensis alias: (S) -2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl] -4-acetylaminoisoindoline-1,3 -diketone
Anglicus operis nomen: Apremilast
Cas#608141-41-9
Formulae hypotheticae: C22H24N2O7S
Pondus hypotheticum: 460.5
(+)-N-[2-[1(S)-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4 -yl]acetamide est medicamentum psoriaticum arthritis, psorasis et arthritis psoriatica medicamentum.

Lege plusMitte Inquisitionem
Apremilast API

Apremilast API

Seres operis nomen: Aprester
Sinensis alias: (S) -2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl] -4-acetylaminoisoindoline-1,3 -diketone
Anglicus operis nomen: Apremilast API
Cas#608141-41-9
Formulae hypotheticae: C22H24N2O7S
Pondus hypotheticum: 460.5

Lege plusMitte Inquisitionem
Arthritis Iguratimod

Arthritis Iguratimod

Seres operis nomen: Ellamod
Sinensis alias: N-[3-(carboxamido)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide
Anglicus productum nomen: Arthritis Iguratimod
CAS#123663-49-0
Formulae hypotheticae: C17H14N2O6S
Pondus hypotheticum: 374.3679
Species et possessiones: cerussa
Adnotationis domesticae numerus API: Y20190021542

Lege plusMitte Inquisitionem
Arthritis rheumatica Iguratimod

Arthritis rheumatica Iguratimod

Seres operis nomen: Ellamod
Sinensis alias: N-[3-(carboxamido)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide
Anglicus productum nomen: Rheumatica Arthritis Iguratimod
Cas#123663-49-0
Formulae hypotheticae: C17H14N2O6S
Pondus hypotheticum: 374.3679
Species et possessiones: cerussa
Adnotationis domesticae numerus API: Y20190021542

Lege plusMitte Inquisitionem
CAS NO.123663-49-0

CAS NO.123663-49-0

Seres productum nomen: Ellamod
Sinensis alias: N-[3-(carboxamido)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide
Anglicus operis nomen: Iguratimod
CAS NO.123663-49-0
Formulae hypotheticae: C17H14N2O6S
Pondus hypotheticum: 374.3679
Species et possessiones: cerussa
Adnotationis domesticae numerus API: Y20190021542

Lege plusMitte Inquisitionem
CAS 123663-49-0

CAS 123663-49-0

Seres operis nomen: Ellamod
Sinensis alias: N-[3-(carboxamido)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide
Anglicus operis nomen: Iguratimod
CAS 123663-49-0
Formulae hypotheticae: C17H14N2O6S
Pondus hypotheticum: 374.3679
Species et possessiones: cerussa
Adnotationis domesticae numerus API: Y20190021542

Lege plusMitte Inquisitionem
Quiescere potes ex officina nostra emere Active Pharmaceutical Ingredient (API) in Sinis. Pharmaceutical Run'an professionalis Sinarum Active Pharmaceutical Ingredient (API) fabrica et supplementum, qualitas products alta praebere possumus. Grata res emendas ex officina nostra.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept